Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127261022 | 12726102 | 2 | F | 20160722 | 20160908 | 20160908 | 20160915 | EXP | IT-UCBSA-2016034352 | UCB | 32.01 | YR | M | Y | 0.00000 | 20160915 | MD | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127261022 | 12726102 | 1 | PS | KEPPRA | LEVETIRACETAM | 1 | Oral | 1500MG ,DAILY | U | 21035 | FILM-COATED TABLET | ||||||||
| 127261022 | 12726102 | 2 | SS | KEPPRA | LEVETIRACETAM | 1 | Oral | UNK | U | 21035 | FILM-COATED TABLET | ||||||||
| 127261022 | 12726102 | 3 | SS | QUETIAPINE. | QUETIAPINE | 1 | 400 MG, TOTAL | U | 0 | 400 | MG | 1X | |||||||
| 127261022 | 12726102 | 4 | SS | Depakin chrono | VALPROIC ACID | 1 | Oral | 3 DF | U | 0 | PROLONGED-RELEASE TABLET | ||||||||
| 127261022 | 12726102 | 5 | SS | Depakin chrono | VALPROIC ACID | 1 | Oral | UNK | U | 0 | PROLONGED-RELEASE TABLET | ||||||||
| 127261022 | 12726102 | 6 | SS | Nozinan | LEVOMEPROMAZINE | 1 | Oral | 1 DF, TOTAL | U | 0 | 1 | DF | FILM-COATED TABLET | 1X | |||||
| 127261022 | 12726102 | 7 | C | Etiltox | DISULFIRAM | 1 | Oral | 200 MG, UNK | U | 0 | 200 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127261022 | 12726102 | 1 | Product used for unknown indication |
| 127261022 | 12726102 | 3 | Product used for unknown indication |
| 127261022 | 12726102 | 4 | Product used for unknown indication |
| 127261022 | 12726102 | 6 | Product used for unknown indication |
| 127261022 | 12726102 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127261022 | 12726102 | OT |
| 127261022 | 12726102 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127261022 | 12726102 | Bradyphrenia | |
| 127261022 | 12726102 | Drug abuse |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127261022 | 12726102 | 2 | 20160721 | 20160722 | 0 | |
| 127261022 | 12726102 | 3 | 20160721 | 20160722 | 0 | |
| 127261022 | 12726102 | 5 | 20160721 | 20160722 | 0 | |
| 127261022 | 12726102 | 6 | 20160721 | 20160721 | 0 |